 |
The Cannabis Conversation | Medical Cannabis | CBD | HempAuthor: Anuj Desai
The cannabis industry is gaining traction across the world, as new medical discoveries, and multi-billion dollar businesses are grabbing the headlines on a regular basis. Experts predict the worldwide industry could be worth in excess of 300bn within 10 years, with Europe forming the biggest market within that, so there's plenty to get excited about. I want to find out more about what's happening, and I'm bringing you along for the ride. Join me - Anuj Desai - as I speak to a wide variety of guests who are helping to shape this nascent sector. Having interviewed over 100 guests, including patients, lawyers, doctors, scientists, entrepreneurs, investors and many more, we discover how, and why, this much maligned and misunderstood plant is giving birth to a huge global business. Language: en-gb Genres: Business, Nature, Science Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
EPISODE #194 Examining Medical Cannabis in Practice with Franjo Grotenhermen, M.D., Chairperson at IACM
Episode 194
Thursday, 16 November, 2023
On the latest episode of The Cannabis Conversation, we speak with Dr. Franjo Grotenhermen, Chairperson at the International Association of Cannabinoid Medicines (IACM).We explore his journey into cannabis medicine, its diverse uses, and the challenges of its regulation. Together, we look at the importance of patient experiences and the need for a balance between clinical trials and real-world experiences. We also examine the risk profile of cannabis, potential side effects, contraindications, and interactions with other medications. The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.Get in touch at www.luminorecruit.com/About Franjo Grotenhermen M.D.Franjo Grotenhermen graduated in medicine and received his doctorate in Cologne. His fields of practice included internal medicine, surgery and naturopathy. He is head of the Centre for Cannabis Medicine in Steinheim (NRW) with a focus on therapy with cannabis and cannabinoids. Grotenhermen is Executive Director of the Arbeitsgemeinschaft Cannabis als Medizin e.V. (ACM) (since 1997), Executive Director of the International Alliance for Cannabinoid Medicines (IACM) (since 2000) and author of the IACM-Bulletin, which is published fortnightly in several languages on the IACM website.Grotenhermen is an employee of the Cologne-based nova Institute, co-owner of Endoxo GmbH (founded in 2019), a company that produces CBD and other hemp products. He is a lecturer at Dresden International University. He is Chief Medical Advisor of canncura, an internet platform for telemedicine in the field of cannabis and cannabinoids. He is a member of the Scientific Advisory Board of the journals Cannabis and Cannabinoid Research, edited by Prof. Daniele Piomelli at Mary Ann Liebert Publishing. He received the following awards: Hanf-Preis 1999 of Cannabusiness, IACM 2011 Special Award, ICBC 2018 Lifetime Achievement Award, Robert Newman Memorial Award 2018 of Akzept e.V., Honorary Award GFS-Award 2021 of Gemeinnützige Forschungsvereinigung Saluplanta e.V.ResourcesConnect with Franjo on LinkedIn: linkedin.com/in/franjo-grotenhermen-65624b19bIACM’s Website: https://cannabis-med.org/
